Where NAMs stand in early drug discovery: an expert discussion

New approach methodologies (NAMs) are becoming an established part of early drug discovery. Human-relevant in vitro systems, advanced imaging and computational models are increasingly used to inform experimental design and decision making.

Despite this progress, adoption remains uneven. Many teams are still working through how to integrate these methods into established workflows and use them confidently in decision making.

This roundtable brings together leading experts to explore where NAMs are delivering value today and what needs to change for broader, more confident adoption.

Why attend

Walk away with a clearer picture of how NAMs are being applied in real discovery workflows and what is still holding teams back:

• Where NAMs are informing early discovery decisions today

• How human-relevant models are evolving and where they provide the most value

• The role of data-rich approaches and integration in decision making

• Where NAMs provide advantages over traditional animal models and where gaps remain

• Challenges around validation, trust and workflow integration

• What is required for broader and more consistent adoption.

Register now to watch on-demand!